DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Tiapride is an investigational drug.
There have been 5 clinical trials for Tiapride. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2012.
The most common disease conditions in clinical trials are Disease, Tourette Syndrome, and Schizophrenia. The leading clinical trial sponsors are Fundación Pública Andaluza Progreso y Salud, Instituto de Salud Carlos III, and Tasly Pharmaceuticals, Inc.
Recent Clinical Trials for Tiapride
|Pharmacovigilance in Gerontopsychiatric Patients||Hannover Medical School||Phase 3|
|Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis||Instituto de Salud Carlos III||Phase 3|
|Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis||Fundación Pública Andaluza Progreso y Salud||Phase 3|